Portfolio News

    Sofinnova Industrial Biotech

    DMC appoints Kelly Smith as VP R&D

    Related Strategy

    Industrial Biotech

    Related Deal lead

    Joško Bobanović

    Related Company

    DMC Biotechnologies

    15 March 2022  Kelly Smith, Ph.D., has joined DMC Biotechnologies as VP R&D. Previously, she was head of bioprocessing and formulation development at Joyn Bio. Kelly has more than 20 years of experience building and leading research and development teams and has a Ph.D. in Environmental Engineering Science from the California Institute of Technology.

    Kelly has a broad diversity of experience in both start-up and large companies, including multiple product launches from concept to commercial. She has diverse technical experience across a range of roles and functions, and experience in a variety of product and application areas.

    Matt Lipscomb, Ph.D., CEO & co-founder of DMC said, “Kelly has exceptional leadership qualities with a track record of building engaged, high-trust and high-results teams. As we expand our operations at DMC, we are excited to welcome Kelly to the team.”

    DMC’s technology platform addresses the key barriers that have plagued the biotech industry for decades including standardization, robustness, and predictability across scale. Addressing these challenges translates to a dramatic reduction in the time to market and the investment needed to bring products to commercialization.

    DMC media contact:
    Kathryn Sheridan
    Sustainability Consult
    media@dmcbio.com

    About DMC

    DMC is a U.S. bio-based chemical company that makes products using microbial fermentation. DMC’s proprietary technology platform simplifies the engineering of biology and makes fermentation more standardized, robust, and predictable.

    For more information, visit: www.dmcbio.com

    Join our mailing list

    Keep up to date with our latest news.

    Required
    Thanks for submitting the form. You are now subscribed to Sofinnova Partners news alerts.An error happened. Please try again later.

    Join our mailing list

    Keep up to date with our latest news.

    Required
    Thanks for submitting the form. You are now subscribed to Sofinnova Partners news alerts.An error happened. Please try again later.